FDA Expands Approval of Drug to Stave Off Type 1 Diabetes
The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type 1 diabetes to the symptomatic form, to include treatment in kids as young…
The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type 1 diabetes to the symptomatic form, to include treatment in kids as young…
Older people with type 1 diabetes had a nearly threefold higher risk of dementia compared with those without diabetes.Type 1 diabetes may present a unique set of dementia risks, in…
Children born to mothers with any diabetes type in Ontario, Canada, had a higher risk of developing epilepsy.For children of mothers with type 1 or type 2 diabetes, epilepsy risk…
Tirzepatide was noninferior to dulaglutide in reducing a composite of cardiovascular events in people with type 2 diabetes and existing heart disease.Both agents are currently approved for type 2 diabetes,…
Due to sponsored search results — a form of online advertising — the Ozempic formulation of semaglutide appears in Google searches for weight loss, despite not being FDA-approved for this…
Patients should not use smart watches or smart rings alone to measure blood sugar levels. FDA warned on wednesday. Non-invasive devices that do not prick the finger or pierce the…